Immatics
overview of patient characteristics and responses | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
19 of 75
Related slides by other companies
AstraZeneca
Results
November 2024
inflammatory diseases a a | AstraZeneca
Oculis
Investor Conference
June 2023
recap first retina eye drop for | Oculis
AstraZeneca
Results
November 2024
inhibitor | AstraZeneca
Nuvalent
Investor Presentation
October 2022
cohort accrual phase dose | Nuvalent
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights